Premier CEO Susan DeVore leaves

  • Push-out Score determined
  • After eight years in the position
  • Praise, thanks and good wishes for DeVore
  • Mike Alkire taking over
  • DeVore said 112 words

(exechange) — Charlotte, North Carolina, February 2, 2021 — Susan DeVore, chief executive of Premier, leaves. As announced by Premier Inc. in a news release and in a regulatory filing published on Tuesday, February 2, 2021, Susan D. DeVore leaves her post as chief executive officer of the healthcare improvement company after eight years in the role, effective May 1, 2021.

Susan DeVore’s duties as CEO will be taken over by Michael J. (Mike) Alkire, currently president of Premier Inc.

“Charitable, philanthropic and personal interests”

Susan DeVore’s departure from the CEO post is explained as follows. Premier said: “Ms. DeVore is retiring to pursue charitable, philanthropic and personal interests and not due to a disagreement with the Company’s management or the Board.”

“Today’s announcement is the culmination of the Board’s diligent, long-range succession planning process and comes at a time when the company is well positioned to further advance its strategic objectives and create long-term stockholder value,” said Board Chair Terry Shaw.

Precise information regarding Susan DeVore’s future plans was not immediately available.


Premier said: “[A]fter nearly 18 years of distinguished service, Susan DeVore is retiring as the company’s chief executive officer and a member of its Board of Directors, effective May 1, 2021.”

Premier further said: “Susan D. DeVore is retiring on June 30, 2021 and will step down as the Chief Executive Officer of the Company and from the Board and its committees effective May 1, 2021.”

Share price increase since February 2018

The announcement follows an increase in Premier Inc.’s share price of 6% since February 2018.

Chaired by Terry Shaw

Terry Shaw serves as Premier Inc.’s Chairman.

In the position of CEO since 2013

Susan DeVore became CEO of the Company in 2013.

To ensure a smooth transition, DeVore will remain with Premier through June 30, 2021, and will continue as an advisor to the company for two years after that.

Susan DeVore is the CEO of Premier with approximately 30 years of experience.

DeVore’s tenure with Premier has centered on driving innovation in healthcare and leading the industry through profound change by engaging stakeholders to co-develop solutions that support high-quality, efficient and sustainable care delivery models.

DeVore is an industry-leading thinker who has consistently been named multiple times to Modern Healthcare’s 100 Most Influential People and Top 25 Women in Healthcare lists.

She recently received the Charlotte Business Journal’s 2018 Women in Business Lifetime Achievement Award, was named to Becker’s Hospital Review’s 2017 100 Great Healthcare Leaders to Know and was recognized as a 2016 UNC Charlotte Distinguished Alumnus.

DeVore is a member of the Board of Directors and the Audit Committee and Risk and Finance Committee of Unum Group, a NYSE-listed company.

She is a non-voting member of the audit and finance committees of the Board of Directors of AdventHealth. DeVore is also a member of the Board of Directors or member of non-profit and state-based organizations, including the Healthcare Leadership Council, the Coalition to Protect America’s Healthcare, the Institute of Medicine Roundtable on Value and Science Driven Healthcare, and the UNC Charlotte Board of Trustees.

Under DeVore’s leadership, Premier has been named as one of the World’s Most Ethical Companies for the past 11 years, received the Malcolm Baldrige National Quality Award and earned the Best in KLAS title for Overall Healthcare Management Consulting.

DeVore obtained a bachelor’s degree from the University of North Carolina at Charlotte and a Master of Management degree from McGill University.

Push-out Score determined

The Push-out Score™ determined by exechange gauges the pressure surrounding Susan DeVore’s move on a scale of 0 to 10.

exechange reached out to Premier and offered the company the opportunity to comment on the score.

Read the full story in the exechange report 6.2021 ($).